Evidence map›Paper›PMID 28713370›Full record

ArticleFrontiers in immunology2017

Persistence of Activated and Adaptive-Like NK Cells in HIV

Anna C Hearps, Paul A Agius, Jingling Zhou, Samantha Brunt, Mkunde Chachage, Thomas A Angelovich, Paul U Cameron, Michelle Giles, Patricia Price, Julian Elliott and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. IL-18 Responsiveness Defines Limitations in Immune Help for Specialized FcRγJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  14. Sex Differences in the Treatment of HIV.Current HIV/AIDS reports · 2020
    Review
  15. Article
  16. Review
  17. Adaptive NKG2CFrontiers in immunology · 2018
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Anna C HearpsCentre for Biomedical Research, Burnet Institute, Melbourne, VIC, Australia.
Paul A AgiusDepartment of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Jingling ZhouCentre for Biomedical Research, Burnet Institute, Melbourne, VIC, Australia.
Samantha BruntPathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia.
Mkunde ChachageCentre for Biomedical Research, Burnet Institute, Melbourne, VIC, Australia.
Thomas A AngelovichCentre for Biomedical Research, Burnet Institute, Melbourne, VIC, Australia.
Paul U CameronDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Michelle GilesDepartment of Infectious Diseases, Monash University, Melbourne, VIC, Australia.
Patricia PriceSchool of Biomedical Science, Curtin University, Perth, WA, Australia.
Julian ElliottDepartment of Infectious Diseases, Monash University, Melbourne, VIC, Australia.
Anthony JaworowskiCentre for Biomedical Research, Burnet Institute, Melbourne, VIC, Australia.
Monash University · AUBurnet Institute · AUThe Alfred Hospital · AUCurtin University · AUUniversity of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Innate immune dysfunction persists in HIV

Indexed as

adaptive-like NK cellcombination antiretroviral therapyHIVimmune activationNK cell

Identifiers

PMID28713370
PMCPMC5491541
OpenAlexW2727605124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.